Key Insights

Highlights

Success Rate

91% trial completion (above average)

Published Results

28 trials with published results (18%)

Research Maturity

108 completed trials (68% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

7.0%

11 terminated out of 158 trials

Success Rate

90.8%

+4.2% vs benchmark

Late-Stage Pipeline

45%

71 trials in Phase 3/4

Results Transparency

26%

28 of 108 completed with results

Key Signals

28 with results91% success11 terminated

Data Visualizations

Phase Distribution

132Total
Not Applicable (27)
Early P 1 (3)
P 1 (12)
P 2 (19)
P 3 (22)
P 4 (49)

Trial Status

Completed108
Unknown18
Terminated11
Recruiting10
Not Yet Recruiting4
Withdrawn3

Trial Success Rate

90.8%

Benchmark: 86.5%

Based on 108 completed trials

Clinical Trials (158)

Showing 20 of 20 trials
NCT05669001Phase 2CompletedPrimary

A Study of TCD601 in de Novo Renal Transplant Recipients

NCT07533669Not ApplicableRecruitingPrimary

Effect of a Preoperative Sensory Modulation Room on Pain, Anxiety, and Sleep in Kidney Transplant Patients

NCT07542028Not ApplicableRecruitingPrimary

Comparison of the Analgesic Effects of TFPB in Renal Transplantation Surgery

NCT01435291Phase 4CompletedPrimary

AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation

NCT03504241Phase 1Completed

Tolerance by Engaging Antigen During Cellular Homeostasis

NCT04844814Phase 2Suspended

Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation

NCT07333105Not ApplicableCompleted

Whole Body Vibration Versus Aerobic Training on Interleukin 6 and Endurance After Renal Transplantation

NCT03024229Not ApplicableCompletedPrimary

Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine

NCT07294183Not ApplicableRecruitingPrimary

The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation

NCT02444429Phase 3CompletedPrimary

3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation

NCT07045467Phase 1Recruiting

Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study

NCT06026592Recruiting

Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients

NCT00396435Phase 4Completed

Correction of Anaemia and Progression of Renal Failure on Transplanted Patients

NCT06406179Not ApplicableRecruitingPrimary

Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients"

NCT02238418Phase 4Completed

Efficacy of Usual Vitamin D Supplementation and Its Impact on Children and Adolescents Calciuria.

NCT03478215Phase 2Active Not RecruitingPrimary

Mesenchymal Stromal Cells in Living Donor Kidney Transplantation

NCT03750331Not ApplicableActive Not RecruitingPrimary

Impact of the Use of Remote Monitoring in the Follow-up of the Renal Transplant Patient.

NCT06744400Phase 1Not Yet RecruitingPrimary

Optimal Dose of Anti-lymphocyte Globulin in Kidney Transplant Recipients With Low Immunological Risk

NCT06674031Recruiting

Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients

NCT06706154RecruitingPrimary

Exercise Capacity in Kidney Transplant Recipients

Scroll to load more

Research Network

Activity Timeline